Safety and efficacy of glucose-insulin-potassium treatment in coronary artery bypass graft surgery and percutaneous coronary intervention.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Interactive Cardiovascular and Thoracic Surgery

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/icvts/ivv222PMID 26265069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myocardial protection by glucose-insulin-potassium in acute coronary syndrome patients undergoing urgent multivessel off-pump coronary artery bypass surgery.

  2013cited by this paper
• Glucosa-Insulin-Potassium (GIK) solution used with diabetic patients provides better recovery after coronary bypass operations.

  2013cited by this paper
• Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.

  2012cited by this paper
• Postoperative N-terminal pro-brain natriuretic peptide level in coronary artery bypass surgery with ventricular dysfunction after perioperative glucose-insulin-potassium treatment.

  2012cited by this paper
• Effect of prophylactic low dose of methylprednisolone on postoperative new atrial fibrillation and early complications in patients with severe LV dysfunction undergoing elective off-pump coronary artery bypass surgery.

  2011cited by this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cited by this paper
• Alpha1-Antitrypsin Deficiency Carriers, Serum Alpha 1-Antitrypsin Concentration, and Non-small Cell Lung Cancer Survival

  2011cited by this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cited by this paper
• A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction.

  2010cited by this paper
• High-dose glucose–insulin–potassium has hemodynamic benefits and can improve cardiac remodeling in acute myocardial infarction treated with primary percutaneous coronary intervention: From a randomized controlled study

  2010cited by this paper
• Efficacy of Glucose-Insulin-Potassium Infusion on Left Ventricular Performance in Type II Diabetic Patients Undergoing Elective Coronary Artery Bypass Graft.Dy

  2010cited by this paper
• The effect of glucose–insulin–potassium treatment on myocardial oxidative stress in patients with acute coronary syndromes undergoing percutaneous coronary intervention

  2008cited by this paper
• Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery.

  2008cited by this paper
• Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

  2007cited by this paper
• Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATEECLA Randomized Controlled Trial

  2006cited by this paper
• Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.

  2006cited by this paper
• Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction.

  2006cited by this paper
• Anti‐inflammatory effect of high‐dose insulin treatment after urgent coronary revascularization surgery

  2006cited by this paper
• Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial.

  2006cited by this paper
• Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction: Implications for Patients With and Without Recognized Diabetes

  2005cited by this paper
• Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction.

  2005cited by this paper
• Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

  2005cited by this paper
• Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).

  2005cited by this paper
• Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization.

  2005cited by this paper
• Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events

  2004cited by this paper
• A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.

  2004cited by this paper
• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

  2003influential reference
• Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.

  2003cited by this paper
• Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery.

  2002cited by this paper
• Physiological insulin concentrations protect against ischemia-induced loss of cardiac function in rats.

  2002cited by this paper
• The insulin cardioplegia trial: myocardial protection for urgent coronary artery bypass grafting.

  2002cited by this paper
• Coronary revascularization: a procedure in transition from on-pump to off-pump? The role of glucose-insulin-potassium revisited in a randomized, placebo-controlled study.

  2002cited by this paper
• The Effect of Insulin Cardioplegia on Atrial Fibrillation After High-Risk Coronary Bypass Surgery: A Double-Blinded, Randomized, Controlled Trial

  2001cited by this paper
• Insulin cardioplegia for elective coronary bypass surgery.

  2001cited by this paper
• Metabolic modulation of acute myocardial infarction.

  2001influential reference
• Insulin (GIK) improves central mixed and hepatic venous oxygenation in clinical cardiac surgery.

  2001cited by this paper
• Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes.

  2001cited by this paper
• Insulin cardioplegia for elective coronary bypass surgery.

  2000cited by this paper
• Myocardial substrate metabolism influences left ventricular energetics in vivo.

  2000cited by this paper
• Insulin(GIK) improves myocardial metabolism in patients during blood cardioplegia.

  2000cited by this paper
• Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury.

  2000cited by this paper
• Is skeletal muscle luxury perfusion the main hemodynamic effect of high-dose insulin in cardiac surgery?

  2000cited by this paper
• Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs.

  2000cited by this paper
• ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate.

  2000cited by this paper
• Low-Dose Glucose-Insulin-Potassium Is Ineffective in Acute Myocardial Infarction: Results of a Randomized Multicenter Pol-GIK Trial

  1999cited by this paper
• Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial

  1998cited by this paper
• Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group.

  1998cited by this paper
• Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting.

  1997cited by this paper
• The Use of Glucose and Insulin during Hypothermic and Normothermic CABG a

  1996cited by this paper
• Perioperative glucose-insulin-potassium infusion in elective coronary surgery: minor benefit in connection with blood cardioplegia?

  1994cited by this paper
• Influence of glucose-insulin-potassium on left ventricular function during coronary artery bypass grafting.

  1993cited by this paper
• Prebypass glucose-insulin-potassium infusion in elective nondiabetic coronary artery surgery patients.

  1992cited by this paper
• Efficacy of metabolic support with glucose-insulin-potassium for left ventricular pump failure after aortocoronary bypass surgery.

  1989cited by this paper
• Hypokalemia from beta2-receptor stimulation by circulating epinephrine.

  1985cited by this paper
• Hypokalemia from beta 2-receptor stimulation by circulating epinephrine.

  1983cited by this paper
• Insulin sensitivity and glucose uptake in the course of surgical treatment for valvular aortic stenosis.

  1982cited by this paper
• Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction.

  1982cited by this paper
• Effect of high-dose fentanyl anaesthesia on the metabolic and endocrine response to cardiac surgery.

  1981cited by this paper
• Glucose substrate in myocardial protection.

  1980cited by this paper
• Influence of Glucose, Insulin, and Potassium on Vulnerability to Ventricular Fibrillation in the Canine Heart

  1978cited by this paper
• Reduction of intraoperative myocardial infarction by means of exogenous anaerobic substrate enhancement: prospective randomized study.

  1978cited by this paper
• Insulin, growth hormone and catecholamines as regulators of energy metabolism in the course of surgery.

  1978cited by this paper
• Effect of operative stress on plasma catecholamine levels.

  1972cited by this paper
• The glucose hypothesis: Relation to acute myocardial ischaemia

  1970cited by this paper
• Intravenous glucose tolerance, insulin, glucose, and free fatty acid levels after myocardial infarction

  1969influential reference
• Malaria in Britain.

  1969cited by this paper
• The continuous estimation of catecholamine release in the early stages of myocardial infarction in the dog.

  1968influential reference
• Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion.

  1966influential reference

• Effect of glucose-insulin-potassium on lactate levels at the end of surgery in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: study protocol for a randomized controlled trial

  2024cites this paper
• Effect of preinitiated glucose-insulin-potassium strategy for patients with undergoing planned percutaneous coronary intervention: a systematic review and meta-analysis

  2023cites this paper
• Cardioprotection with glucose insulin potassium (GIK) during non cardiac surgery in a patient with stress induced myocardial ischemia: A case report

  2022cites this paper
• Cardioprotective Effects of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery: a Systematic Review and Meta-Analysis.

  2022influential citation
• Risk and protective factors for atrial fibrillation after cardiac surgery and valvular interventions: an umbrella review of meta-analyses

  2022cites this paper
• Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data

  2022cites this paper
• Myocardial Protection with Glucose-Insulin-Potassium Infusion during Cardiopulmonary Bypass for Coronary Revascularization

  2021influential citation
• Effectiveness of glucose-insulin–potassium infusion for myocardial protection in non-diabetic patients during adult cardiac surgery

  2020cites this paper
• Effect of Perioperative Glucose-Insulin-Potassium Therapy in Patients Undergoing On-Pump Cardiac Surgery: A Meta-Analysis.

  2020cites this paper
• The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation.

  2020cites this paper
• Синдром низкого сердечного выброса в кардиохирургии

  2019cites this paper
• Low cardiac output syndrome in cardiac surgery

  2019cites this paper
• Pretreatment with glucose–insulin–potassium improves ventricular performances after coronary artery bypass surgery: a randomized controlled trial

  2019cites this paper
• Myocardial Protection by Glucose–Insulin–Potassium in Moderate- to High-Risk Patients Undergoing Elective On-Pump Cardiac Surgery: A Randomized Controlled Trial

  2018cites this paper
• Low-Cardiac-Output Syndrome After Cardiac Surgery.

  2017cites this paper
• Myocardial protection with Glucose-Insulin-Potassium infusion during adult cardiac surgery

  2017cites this paper
• Glycemic Control in Coronary Revascularization

  2016cites this paper